NEW YORK, March 23, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Natus Medical Incorporated (“Natus” or the “Company”) (NASDAQ:BABY) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Natus Medical Incorporated securities between October 16, 2015 and April 3, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/baby.
The class action lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose material adverse facts about Natus’ business, operations, and prospects, including that: (1) the Venezuelan government failed to make tens of millions of dollars in prepayments to Natus, which were required to have been paid beginning in October 2015; (2) Natus had no means to effectively enforce its rights under its supply contract, as Venezuela was the exclusive forum for dispute resolution; (3) Natus’ receipt of revenues pursuant to the supply contract was contingent on the outcome of Venezuelan elections; and (4) consequently, Natus was not on track to achieve the increased guidance provided by Defendants, which lacked a reasonable basis. Once this information was made known to the investing public, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/baby or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Natus you have until March 31, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 



